To identify the most important attributes related to the process of achieving, and outcomes associated with, successful care for differences of sex development (DSD).
We developed a best–worst scaling survey administered to 520 DSD stakeholders, including individuals or family members of those with DSD, health care specialists, and patient support and advocacy representatives. Fourteen process-related attributes and 16 outcome-related attributes were identified through qualitative research. We estimated relative importance scores and coefficients from regression analysis to understand the relative importance of attributes and conducted latent class analysis to explore heterogeneity in preferences.
The 3 most important process attributes were (1) good communication between care team and patient/family, (2) care team educated patient/family about condition, and (3) care team incorporates the values of patient/family. The 3 most important outcome attributes were (1) patient satisfaction, (2) patient mental health, and (3) treatment maintains physical health. Latent class analyses showed that respondents had heterogeneous preferences. For process-related attributes, we identified 3 respondent groups: “Patient autonomy and support” (46% of respondents), “Education and care transitions” (18%), and “Shared decision-making” (36%). For outcome-related attributes, we identified 2 respondent groups: “Preserving function and appearance” (59% of respondents) and “Patient health and satisfaction” (41%).
Outcomes such as patient satisfaction and health were the most important outcome attributes, and good communication and education from the care team were the most important process attributes. Respondents expressed heterogeneous preferences for selected DSD care attributes that providers should consider to improve satisfaction with and quality of DSD care.
Divergent views about what constitutes “successful” or “best” care for individuals with differences of sex development may lead to treatment decisions that are misaligned with the interests of patients and parents, negatively impacting quality of life.
This best-worst scaling survey of 520 differences of sex development (DSD) stakeholders identified the most important factors of DSD care such as patient- and family-centered attributes and found distinct respondent subgroups with varied preferences for specific attributes.
Differences of sex development (DSD) are individually rare congenital conditions defined by atypical development of chromosomal, gonadal, or anatomic sex.1 DSD (sometimes referred to as “disorders of sex development,” “intersex traits,” or “variations of sex development”) include ∼60 conditions that fall into 1 of 3 types: sex chromosome variations (sex chromosome DSD); conditions affecting testis development and androgen synthesis and action (46,XY DSD); and conditions affecting ovary development or androgen excess (46,XX DSD).2 ,3 DSD are associated with increased risk of infertility,4 ,5 gonadal cancer,6 –8 and hypogonadism,8 ,9 as well as perceived anatomic and cosmetic obstacles to satisfying sexual function.10 –12 Concurrently, these features are accompanied by an elevated risk of gender dysphoria,13 psychosocial distress,14 –16 and pervasive challenges to psychosocial adaptation for patients and their families.17 –19
International consensus statements20 ,21 call for DSD care to be delivered by interprofessional health care teams comprising specialists who provide medical, surgical, and psychosocial care to patients and their families throughout their lifespan.1 ,22 Divergent views about “successful” or “best” DSD care among stakeholders may lead to treatment decisions that do not align with the interests and priorities of patients and parents, negatively impacting quality of life.23 ,24 For example, some DSD advocates believe in withholding elective surgical treatments until patients can meaningfully participate in decision-making.25 ,26 Parents, however, may seek such interventions to “normalize” the appearance and/or function of atypical genitals or remove gonads at higher risk for developing a gonadal tumor or secreting sex hormones at puberty discordant with the child’s gender of rearing and identity. The conflicting values and perspectives related to DSD care, however, remain understudied, despite their influence on clinical management.
Understanding the preferences of patients, family members, advocates, and providers can inform and improve the patient- and family-centeredness of DSD care. In this study, we administered a best-worst scaling survey to identify the most important attributes related to the (1) process of achieving and (2) outcomes associated with successful DSD care.
Methods
This study uses an online best–worst scaling survey to measure relative preferences for process and outcome attributes associated with care decisions for individuals with DSD. Preferences, a concept that comes from economic theory, can be measured based on the choices and tradeoffs people make given a set of alternatives. Preferences can be observed (revealed preferences), as in the case of consumer behavior, or assessed under hypothetical conditions in surveys (stated preference).27 Best–worst scaling is a type of stated preference method that has been used in many areas, including health care decision-making,28 to measure preferences and tradeoffs based on the different qualities or attributes of goods and services.29 In best–worst scaling, respondents are asked to make tradeoffs by selecting the best and worst attributes in a set. By providing 2 choices, best–worst scaling elicits more information about a respondent’s preferences than ranking and rating exercises or other conjoint analyses, allowing for the calculation of a quantitative relative value weighting across attributes.
Survey Design
The survey was developed following best practices for stated preference methods.30 First, in-depth qualitative interviews with DSD stakeholders (n = 110) were conducted to understand stakeholder perspectives regarding optimal care delivery and outcomes for individuals with DSD. Information from these interviews, which have been described previously,24 were used to identify and define 14 attributes related to the process of achieving successful DSD care (process attributes) and 16 attributes related to outcomes associated with successful DSD care (outcome attributes; Table 1 and 2). Additional qualitative interviews were conducted to refine, confirm, and prioritize attributes before being included in the best-worst scaling survey. Second, a paper-based survey draft was iteratively pretested among DSD stakeholders (n = 17). Refinements were made to the survey based on the feedback collected from stakeholders through cognitive interviews. In the final stage, an online version of the best–worst scaling survey was coded in Qualtrics (Qualtrics, Provo, UT) and pilot-tested among additional DSD stakeholders (n = 44) to ensure functionality.
Attribute . | Definition . |
---|---|
1. Decision making: Parents make final treatment decisions | Parents/legal guardians serve as the primary decision makers without pressure from the care team in non–life-threatening conditions and situations |
2. Decision making: Patients make final treatment decisions | The patient serves as the primary decision maker once old enough to participate in decision making in non–life-threatening conditions and situations |
3. Decision making: Providers make final treatment decisions | Providers serve as the primary decision makers in non–life-threatening conditions and situations |
4. Delay nonurgent treatments that cannot be reversed | Decisions about nonurgent treatments that cannot be reversed are delayed until the patient is old enough to understand and make decisions |
5. Family educates their child about the condition from early on | Parents/guardians teach their child early on about their condition and its effects in an ongoing, honest way that the child can understand |
6. Open communication with family members and close friends | Parents/guardians share information about their child’s condition with family and close friends |
7. Care team incorporates the values of patient/family | The care team is aware of, and responsive to, all the preferences, cultures, and values of the patient and family, including psychological and spiritual needs |
8. Care team educates the patient/family about the condition | The care team educates the patient and family about the patient’s medical condition and how it may affect the patient’s well-being and health |
9. Care team provides the patient/family with skills in sharing with others outside of the family | The care team provides guidance to the patient and family on how to share details about the condition with important people such as friends, relatives, school, or daycarea |
10. Good communication between care team and patient/family | There is complete and consistent communication between the entire care team and the patient/family |
11. Care delivered by a team of specialists in the same location | All specialists work together, in person, to review and deliver patient care in the same location |
12. Availability of support groups/peer mentors | Support groups and/or peer mentors are available to patients and their families. Patients learn about their condition and are supported by someone who has “been there.” |
13. Transition to quality adult care is available | Transition from pediatric to quality adult care is available and happens in a smooth and well-coordinated way |
14. Family supports the patient’s choices | The family is supportive of the patient and their current/future choices and decisions related to their condition when the patient is of an age to make independent choices. This includes when the patient’s choices may be different from what parents might have chosen |
Attribute . | Definition . |
---|---|
1. Decision making: Parents make final treatment decisions | Parents/legal guardians serve as the primary decision makers without pressure from the care team in non–life-threatening conditions and situations |
2. Decision making: Patients make final treatment decisions | The patient serves as the primary decision maker once old enough to participate in decision making in non–life-threatening conditions and situations |
3. Decision making: Providers make final treatment decisions | Providers serve as the primary decision makers in non–life-threatening conditions and situations |
4. Delay nonurgent treatments that cannot be reversed | Decisions about nonurgent treatments that cannot be reversed are delayed until the patient is old enough to understand and make decisions |
5. Family educates their child about the condition from early on | Parents/guardians teach their child early on about their condition and its effects in an ongoing, honest way that the child can understand |
6. Open communication with family members and close friends | Parents/guardians share information about their child’s condition with family and close friends |
7. Care team incorporates the values of patient/family | The care team is aware of, and responsive to, all the preferences, cultures, and values of the patient and family, including psychological and spiritual needs |
8. Care team educates the patient/family about the condition | The care team educates the patient and family about the patient’s medical condition and how it may affect the patient’s well-being and health |
9. Care team provides the patient/family with skills in sharing with others outside of the family | The care team provides guidance to the patient and family on how to share details about the condition with important people such as friends, relatives, school, or daycarea |
10. Good communication between care team and patient/family | There is complete and consistent communication between the entire care team and the patient/family |
11. Care delivered by a team of specialists in the same location | All specialists work together, in person, to review and deliver patient care in the same location |
12. Availability of support groups/peer mentors | Support groups and/or peer mentors are available to patients and their families. Patients learn about their condition and are supported by someone who has “been there.” |
13. Transition to quality adult care is available | Transition from pediatric to quality adult care is available and happens in a smooth and well-coordinated way |
14. Family supports the patient’s choices | The family is supportive of the patient and their current/future choices and decisions related to their condition when the patient is of an age to make independent choices. This includes when the patient’s choices may be different from what parents might have chosen |
DSD, differences of sex development.
For clarity, a minor change to this attribute description was made for this report. The descriptions originally shown to survey respondents are found in Supplemental Information.
Attribute . | Definition . |
---|---|
1. Successful treatment with medicine | Medicine-based treatment (such as hormones) leads to expected results without unwanted effects or complications |
2. Successful treatment with surgery | Surgical treatment leads to expected results without unwanted effects or complications |
3. Successful treatment with psychological intervention | Psychological intervention/treatment such as counseling or therapy leads to expected results without unwanted effects or complications |
4. Treatment (medicine or surgery) maintains physical health | The treatment leads to typical function such as the ability to urinate, helps to avoid risks such as cancer, or replaces missing hormones (for example, adrenal or puberty hormones) |
5. Patient given the specific cause of their condition | Patients receive a genetic or other clear cause for their condition, rather than being told they have a condition that falls under a general group of conditions |
6. Parent/guardian satisfaction | The parents/guardians are satisfied with the health care decisions that were made and the care they have received |
7. Patient satisfaction | The patient is satisfied with the health care decisions that were made and the care they have received |
8. Patient mental health | The patient is mentally and emotionally well-adjusted in relation to their condition |
9. Patient fits into society | The patient is able to fully participate socially and have close friendships or relationships without shame, secrecy, or stigma |
10. Patient is raised by the family either as a boy or as a girl | The patient is raised as a person with a binary gender (for example, as boy or girl, instead of intersex) |
11. Patient is satisfied with their gender | The patient is satisfied with the gender in which they were raised or the patient feels supported in their preferred self-chosen gender, even if different from how they were raised |
12. Sexual function is preserved/satisfying | The person is/will be able to have satisfying and pain-free sexual function |
13. Reproductive function is preserved/possible | The patient is/will be able to have a biological child, with or without the help of medicine (assisted reproductive technologies)a |
14. Typical appearance of genitals | The patient’s genitals look typical for their specified gender. |
15. Typical appearance of body | The patient’s body develops typically or looks typical for their specified gender (such as breasts, facial/body hair, voice, etc), which may or may not align with genetics |
16. Knowledge of the condition | The patient and family have a detailed understanding about the condition, what caused it, and how it may affect the patient’s life and health |
Attribute . | Definition . |
---|---|
1. Successful treatment with medicine | Medicine-based treatment (such as hormones) leads to expected results without unwanted effects or complications |
2. Successful treatment with surgery | Surgical treatment leads to expected results without unwanted effects or complications |
3. Successful treatment with psychological intervention | Psychological intervention/treatment such as counseling or therapy leads to expected results without unwanted effects or complications |
4. Treatment (medicine or surgery) maintains physical health | The treatment leads to typical function such as the ability to urinate, helps to avoid risks such as cancer, or replaces missing hormones (for example, adrenal or puberty hormones) |
5. Patient given the specific cause of their condition | Patients receive a genetic or other clear cause for their condition, rather than being told they have a condition that falls under a general group of conditions |
6. Parent/guardian satisfaction | The parents/guardians are satisfied with the health care decisions that were made and the care they have received |
7. Patient satisfaction | The patient is satisfied with the health care decisions that were made and the care they have received |
8. Patient mental health | The patient is mentally and emotionally well-adjusted in relation to their condition |
9. Patient fits into society | The patient is able to fully participate socially and have close friendships or relationships without shame, secrecy, or stigma |
10. Patient is raised by the family either as a boy or as a girl | The patient is raised as a person with a binary gender (for example, as boy or girl, instead of intersex) |
11. Patient is satisfied with their gender | The patient is satisfied with the gender in which they were raised or the patient feels supported in their preferred self-chosen gender, even if different from how they were raised |
12. Sexual function is preserved/satisfying | The person is/will be able to have satisfying and pain-free sexual function |
13. Reproductive function is preserved/possible | The patient is/will be able to have a biological child, with or without the help of medicine (assisted reproductive technologies)a |
14. Typical appearance of genitals | The patient’s genitals look typical for their specified gender. |
15. Typical appearance of body | The patient’s body develops typically or looks typical for their specified gender (such as breasts, facial/body hair, voice, etc), which may or may not align with genetics |
16. Knowledge of the condition | The patient and family have a detailed understanding about the condition, what caused it, and how it may affect the patient’s life and health |
DSD, differences of sex development.
For clarity, a minor change to this attribute description was made for this report. The descriptions originally shown to survey respondents are found in Supplemental Information.
The best–worst scaling survey instrument included 4 sections: introduction, participation consent, 8 best–worst scaling tasks, and a final section with questions about respondents’ demographics, beliefs, and attitudes. The introduction included descriptions of the 14 process and 16 outcome attributes as well as a sample best–worst scaling task (Fig 1). In answering each task, participants were instructed to imagine the process of obtaining treatment of a child with DSD. (In the final survey and in recruitment materials, we used the term “Conditions Affecting Reproductive Development” instead of DSD because our qualitative research revealed that some stakeholders preferred this term.) Participants were asked to select the “most important” and “least important” attributes for 8 best–worst scaling tasks: 4 for process attributes and 4 for outcome attributes. Each task included a subset of 6 process or outcome attributes for the participant to consider. The subset of attributes included in each question set were determined based on a balanced incomplete block design methodology,29 generated using Stata (StataCorp College Station, TX). In the final section, participants were presented with questions on sociodemographic characteristics, attitudes and beliefs on DSD care (which were pretested and pilot-tested), and experiences completing the survey. Respondents were asked about their racial and ethnic identity to understand the diversity of our sample.
Setting and Participants
Participants, recruited between October 2020 and May 2022, were a sample of 520 DSD stakeholders, including adolescents and adults with DSD, parents of a child with DSD, multidisciplinary health care providers, and allied professionals. Adolescents and adults with DSD and parents with a DSD-affected child were recruited through 3 US pediatric medical centers (n = 133) or through patient support and advocacy organizations (n = 41). Professionals, including health care providers and other stakeholders, were recruited based on evidence of their connection to DSD, similar to a process followed in a previous study (n = 323 from medical centers and n = 23 from advocacy organizations).24 The institutional review board of the University of Michigan Medical School approved the research.
Analyses
Relative importance scores were calculated for each of the 14 process and 16 outcome attributes. The number of times each attribute was chosen as least important was subtracted from the number of times each attribute was chosen as most important, and the difference was divided by the number of times each attribute was available to be chosen by the participants.29 Relative importance scores range from –1 to 1, and their magnitude and direction represent the relative value associated with the attribute. Higher positive scores denote attributes that are selected more often as most important by the participants, whereas lower negative scores denote attributes that are selected more often as least important. Scores close to 0 denote relative indifference to the attribute. We also stratified relative importance scores by selected participant characteristics to explore potential heterogeneity across subgroups in which we had sufficient representation. Primary analysis included all observations, and secondary analyses excluded (1) respondents who did not select both best and worst options or (2) respondents who indicated difficulty answering the questions.
To gain further insight into the relative significance of the attributes, we employed conditional logit regression analysis with effects coding.29 The regression model assumes a sequential best–worst assumption, where respondents are assumed to select the most important attribute before selecting the least important attribute in a list. Coefficients from the regression analyses, which can be negative or positive, were transformed to ratio-scaled preference weights ranging from 0 to 100 using a procedure described elsewhere (Supplemental Information).31
We also conducted latent class analysis (LCA) to explore heterogeneity in preferences. LCA is a probabilistic modeling approach that identifies unobserved or “hidden” group membership based on patterns in preferences.32 ,33 We used conditional logit models to conduct the LCA, and model fit was assessed by minimizing the Bayesian Information Criterion and consistent Akaike Information Criterion.34 All analyses were conducted in Stata.
We used descriptive statistics to summarize respondents’ sociodemographic characteristics and their attitudes and beliefs on DSD care.
Results
Sample characteristics
The characteristics of the 520 survey participants are shown in Table 3 and Supplemental Table 4. Most respondents (n = 272 or 52.3%) were health care providers with expertise in, among others, pediatric urology or surgery (n = 54 or 10.4%), pediatric endocrinology (n = 54 or 10.4%), and psychology or psychiatry (n = 48 or 9.2%). Individuals with DSD (n = 87) or family members of individuals with DSD (n = 89) comprised 33.9% (n = 176) of respondents, followed by other professionals (n = 50 or 9.6%) and advocates (n = 28 or 5.4%). The sample was predominantly White (n = 415 or 79.8%), non-Hispanic (n = 440 or 84.6%), cisgender women (n = 360 or 69.2%), straight/heterosexual (n = 385 or 74.0%), and individuals with postgraduate education (n = 347 or 66.7%).
. | n (%) . |
---|---|
Age, y | |
<18 | 25 (4.8) |
18–29 | 56 (10.8) |
30–39 | 116 (22.3) |
40–49 | 137 (26.4) |
50–59 | 80 (15.4) |
60–69 | 39 (7.5) |
70+ | 11 (2.1) |
Declined or no response | 56 (10.7) |
Ethnicity | |
Hispanic | 27 (5.2) |
Non-Hispanic | 440 (84.6) |
Declined or no response | 53 (10.2) |
Racea | |
White or Caucasian | 415 (79.8) |
Asian, Hawaii Native, or Pacific Islander | 38 (7.3) |
African American or Black | 17 (3.3) |
First Nations, American Indian, or Alaska Native | 4 (0.8) |
Other | 12 (2.3) |
Declined or no response | 34 (6.5) |
Gendera | |
Man | 118 (22.7) |
Woman | 360 (69.2) |
Transgender | 1 (0.2) |
Gender variant/nonconforming | 6 (1.2) |
Other | 1 (0.2) |
Declined or no response | 4 (0.8) |
Sexual orientation | |
Lesbian, gay, or homosexual | 33 (6.3) |
Straight or heterosexual | 385 (74.0) |
Bisexual | 25 (4.8) |
Other | 13 (2.5) |
Declined or no response | 66 (12.7) |
Highest level of education completed | |
Partial high school or less | 25 (4.8) |
High school graduate | 15 (2.9) |
Partial college or specialized training | 34 (6.5) |
College or university graduation | 64 (12.3) |
Graduate/professional training | 347 (66.7) |
Declined or no response | 35 (6.7) |
Connection to DSDa | |
Affected individual | 87 (16.2) |
Parent of affected individual | 87 (16.2) |
Other family member | 2 (0.4) |
Health care provider | 272 (52.3) |
Other professional | 50 (9.6) |
Patient/family advocacy | 28 (5.4) |
Declined or no response | 28 (5.4) |
Importance of religion | |
Very important | 113 (21.7) |
Somewhat important | 116 (22.3) |
Not too important | 122 (23.5) |
Not at all important | 115 (22.1) |
Declined or no response | 56 (10.8) |
. | n (%) . |
---|---|
Age, y | |
<18 | 25 (4.8) |
18–29 | 56 (10.8) |
30–39 | 116 (22.3) |
40–49 | 137 (26.4) |
50–59 | 80 (15.4) |
60–69 | 39 (7.5) |
70+ | 11 (2.1) |
Declined or no response | 56 (10.7) |
Ethnicity | |
Hispanic | 27 (5.2) |
Non-Hispanic | 440 (84.6) |
Declined or no response | 53 (10.2) |
Racea | |
White or Caucasian | 415 (79.8) |
Asian, Hawaii Native, or Pacific Islander | 38 (7.3) |
African American or Black | 17 (3.3) |
First Nations, American Indian, or Alaska Native | 4 (0.8) |
Other | 12 (2.3) |
Declined or no response | 34 (6.5) |
Gendera | |
Man | 118 (22.7) |
Woman | 360 (69.2) |
Transgender | 1 (0.2) |
Gender variant/nonconforming | 6 (1.2) |
Other | 1 (0.2) |
Declined or no response | 4 (0.8) |
Sexual orientation | |
Lesbian, gay, or homosexual | 33 (6.3) |
Straight or heterosexual | 385 (74.0) |
Bisexual | 25 (4.8) |
Other | 13 (2.5) |
Declined or no response | 66 (12.7) |
Highest level of education completed | |
Partial high school or less | 25 (4.8) |
High school graduate | 15 (2.9) |
Partial college or specialized training | 34 (6.5) |
College or university graduation | 64 (12.3) |
Graduate/professional training | 347 (66.7) |
Declined or no response | 35 (6.7) |
Connection to DSDa | |
Affected individual | 87 (16.2) |
Parent of affected individual | 87 (16.2) |
Other family member | 2 (0.4) |
Health care provider | 272 (52.3) |
Other professional | 50 (9.6) |
Patient/family advocacy | 28 (5.4) |
Declined or no response | 28 (5.4) |
Importance of religion | |
Very important | 113 (21.7) |
Somewhat important | 116 (22.3) |
Not too important | 122 (23.5) |
Not at all important | 115 (22.1) |
Declined or no response | 56 (10.8) |
DSD, differences of sex development.
Respondents could select >1 choice.
Relative Importance Scores
Among the 14 process attributes (Fig 2A), good communication between care team and patient/family, care team educates the patient/family about the condition, and care team incorporates the values of patient/family received the highest relative importance scores. The lowest-scoring process attribute was providers make final treatment decisions, followed by care team provides the patient/family with skills in sharing with others outside of the family, care delivered by a team of specialists in the same location, and parents make the final decision, which had similar scores.
The highest-scored outcome attributes (Fig 2B) were patient satisfaction, patient mental health, and treatment maintains physical health. The lowest-scoring outcome attributes were patient is raised by the family either as a boy or as a girl, typical appearance of body, patient is given specific cause of their condition, and typical appearance of genitals. Results were similar even when respondents with incomplete responses or who reported difficulty completing the best–worst scaling tasks were excluded from the analysis.
Between individuals with DSD and parents of affected individuals, we found that both groups had general agreement about the most and least important process-related attributes but showed divergent preferences for some outcome-related attributes (Supplemental Fig. 4). Relative importance scores by age, gender, religiosity, and patient or family member status (versus provider or other professional status) are found in Supplemental Figs. 5–8. Subgroups generally had similar attributes with the highest and lowest relative importance scores, and most variation was observed among the attributes ranked in the middle (scores between –0.1 and 0.1).
Results from the conditional logit regression analysis using data from all respondents identified similar, albeit slightly different rankings of process and outcomes attributes (Supplemental Tables 5 and 6) compared with the relative importance scores. The ratio scale preference weights calculated using the regression coefficients suggest that the most important process and outcomes attributes are at least 20 times as influential as the least important attributes (Supplemental Fig. 9).
Respondent Attitudes and Beliefs
Most respondents (53.8%) agreed with the definition of DSD as a medical condition or disorder of development, whereas just more than one third of respondents said that DSD is a variation of development that should not be medicalized (Supplemental Table 7).
When asked about surgery involving gonads or atypical genitals, 61.3% of respondents indicated that these decisions should be driven by patients themselves when they are old enough to weigh the pros and cons (Supplemental Table 7). A similar proportion of respondents (61.2%) indicated that atypical genitals should be addressed both surgically and psychologically, as opposed to only psychologically (18.8%), only surgically (6.0%), or not addressed (3.8%).
When respondents were asked to quantify relative importance of 5 attributes in a standard rating task, patient mental health received the highest allocation and typical appearance of genitalia received the lowest allocation (Supplemental Table 8).
Respondents who selected “Typical appearance of genitalia” as the least important attribute in any of the best–worst scaling tasks (n = 222) were asked additional questions. When asked whether this attribute was still the least important attribute among all the attributes shown to them, more than half (58.1% or 129) answered “yes” (Supplemental Table 8). Among respondents who answered “no” or “not sure” (n = 74), most respondents (71.6% or 53) said that the other attributes that were presented to them had equal importance (Supplemental Table 8).
In 2 additional questions administered to all participants, using a scale of 1 (no effects) to 10 (significant negative effects), the median rating given by respondents regarding the effects of atypical genitals on a person’s romantic/sexual intimacy and overall quality of life was relatively negative at 7 in both cases (Supplemental Table 8).
Latent Class Analysis
The LCA revealed latent groups of respondents for both sets of attributes (Fig 3). (The sociodemographic characteristics of respondents that fall into each latent group are found in Supplemental Tables 9 and 10). For the process attributes, 3 respondent groups were identified. Most respondents (46%) fell into the “Patient autonomy and support” group, which showed preferences for attributes such as delaying nonurgent and irreversible treatments, care team educating and communicating with the patient/family about the condition, and patients making the final decision (Fig 3A). The second (“Education and care transitions”; 18%) and third (“Shared decision-making”; 36%) respondent groups also valued education and communication from the care team but placed lower emphasis on delaying nonurgent treatments compared with the “Patient autonomy and support” group. Respondents from the “Education and care transitions” group showed stronger preferences for transitions to adult care and receiving skills from the care team on sharing information about the child’s medical condition with others outside the family. The “Shared decision-making” group showed stronger preferences for care delivery in the same location and equal weighting of parents or patients making the final decision.
Two respondent groups were identified for the outcome attributes (Fig 3B): “Preserving function and appearance” (59%) and “Patient health and satisfaction” (41%). Both respondent groups valued overall patient satisfaction, satisfaction with gender, and mental and physical health. However, respondents from the “Preserving function and appearance” group showed stronger preferences for preservation of reproductive and sexual function, as well as successful treatment with psychological intervention, medicine, or surgery. By contrast, the “Patient health and satisfaction” group valued patient knowledge of the condition and integration into the society. More affected individuals and family members (41.6% vs 15.7%, P < .001) were likely to be in the “Preserving function and appearance” group, whereas more health care providers were in the “Patient health and satisfaction” group (73.1% vs 38.4%, P < .001; Supplemental Table 10).
Discussion
This survey study explored the preferences of different stakeholders for attributes related to DSD care using best–worst scaling, a type of stated preference method. The top 3 most important process attributes of 14 related to good communication and education from the care team and the inclusion of patient and family values. Among the 16 outcome attributes, respondents identified patient-focused attributes such as patient satisfaction and mental and physical health as the top 3 most important. The small discrepancy between relative importance scores and conditional logit coefficients implies that DSD stakeholders’ preferences are partially dependent on the set of options they must choose from and the tradeoffs they have to make.
LCA identified latent groups for both process and outcome attributes. Although respondent groups shared several similar preferences, especially for the highest valued attributes, key differences between these groups were also observed. For example, although respondents in the “Patient autonomy and support” group ranked delaying nonurgent and irreversible treatments as the most important process attribute, the 2 remaining groups—“Education and care transitions” and “Shared decision-making”—ranked this attribute as the 12th and fourth most important, respectively. The possible presence of latent groups of respondents with diverse characteristics and who differentially value specific attributes of DSD care emphasizes the importance of incorporating an individual’s and family’s preferences in the decision-making process. Providers should also be aware of their preferences; the LCA found that providers are likely to differ with affected individuals and families in their preferences for outcome-related attributes. Thus, even if clinical recommendations in DSD were based on stronger evidence of long-term outcomes, disparities would persist because of the gap between “best care” in the aggregate versus values-informed decision making. This gap can be addressed through shared decision making, which necessitates a 2-way discussion exploring what ultimately matters most to the patient and their family.35
Our survey revealed that “typical appearance of genitals” ranked 13th of 16 outcome attributes of successful DSD care in the main analysis. Similarly, the 2 outcome-related latent groups ranked this attribute 14th and 11th most important, and both individuals with DSD and parents ranked this among the least important attributes. Instead, overall patient satisfaction, mental and physical health, and satisfaction with gender were rated as the most important outcome attributes of successful DSD care. These observations were unexpected given the amount of attention and controversy surrounding the topic of genital surgery and its effect on another attribute, satisfaction with gender.36 It is possible that when respondents are forced to prioritize important outcomes of care, as in best–worst scaling, they are able to imagine patient satisfaction and well-being in the presence of atypical genital appearance. Notwithstanding these observations, respondents’ median rating of the effect of atypical genitals on a person’s overall quality of life and romantic life/sexual intimacy was 7 of 10 (where 10 equals “significant negative effects”; Supplemental Table 8). This apparent difference in the weighting of attributes according to item format underscores the influence of context when individuals consider the importance of attributes of care. For example, the “focusing illusion” is a cognitive bias that occurs when individuals overestimate the importance of 1 specific factor and believe it has a greater impact on their well-being or happiness than it actually does.37 ,38 The illusion arises from a tendency to focus on a particular aspect of or event in our lives, which results in excessive weight in judgments and a distorted perception of reality. In the clinical setting, when caregivers are first learning about their child’s DSD, they may easily focus on “fixing” atypical genital appearance, fearing that this characteristic will weigh heavily on the child’s future adaptation and well-being. Under these circumstances, consideration of other important factors may not receive adequate or any consideration. To guard against this bias, clinicians can assist decision-makers in considering both harms and benefits associated with every reasonable option available, such as through the use of decision aids.39
This study has several strengths and limitations. We included a limited set of attributes of DSD care in this study. Although these attributes were identified through a multistep qualitative assessment,24 it is possible that other factors important to DSD care may have been omitted. Participants were predominantly non-Hispanic (85%) and White (80%) and may not reflect the full racial and ethnic diversity of DSD stakeholders. However, the investigators, who were from 3 academic medical centers with established interdisciplinary DSD programs and who serve different demographic populations, were able to recruit a large sample of participants representing different DSD stakeholder groups from across the United States.
Conclusions
The study identified the relative value of attributes associated with the process and outcomes of DSD care from a large sample of DSD stakeholders. Although respondents showed general agreement about the most important attributes of care such as patient satisfaction and health and good communication and education from the care team, LCA showed preference heterogeneity for specific attributes. Findings from this study emphasize the importance of incorporating an individual’s and family’s preferences in shared decision-making and increasing awareness about providers’ own preferences that might impact satisfaction with and quality of DSD care.
Acknowledgments
The authors thank Norah Crossnohere and Abram Wagner for their input on the analysis plan.
Dr Avanceña designed the data collection instruments, carried out the analyses, drafted the manuscript, critically reviewed and revised the manuscript, and is the guarantor of the study; Ms Rose and Ms Gardner designed the data collection instruments, coordinated and supervised the data collection, critically reviewed and revised the manuscript, and provided administrative and technical support; Dr Rutter, Ms Schafer-Kalkhoff, Dr Suorsa-Johnson, Dr van Leeuwen, and Ms Weidler coordinated and supervised the data collection and critically reviewed and revised the manuscript; Mr Gebremariam carried out the analyses and critically reviewed and revised the manuscript; Drs Prosser and Sandberg conceptualized, designed, and supervised the study, drafted the manuscript, oversaw the data collection, and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
FUNDING: Eunice Kennedy Shriver National Institute of Child Health & Human Development (R01HD086583) of the National Institutes of Health and the Valuation of Child Health Initiative (VoCHI) and Susan B. Meister Child Health and Evaluation Center at the University of Michigan. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no potential conflicts of interest to disclose.
Comments